MERSANA THERAPEUTICS INC. - COMMON STOCK
3.3600
01-5月-24 15:59:59
15 分の遅延
株式
+0.1900
+5.99%
本日の幅
3.1600 - 3.5900
ISIN
N/A
ソース
NASDAQ
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 4 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 4 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 3 2023 19:10:38 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 2 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
02 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
01 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors
25 1 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 1 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
06 1 2023 07:00:18 提供 Nasdaq GlobeNewswire
-
14 12 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 12 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Jefferies London Healthcare Conference
08 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
07 11 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 11 2022 16:05:00 提供 Nasdaq GlobeNewswire